| 000 | 01091 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516141638.0 | ||
| 264 | 0 | _c20130813 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1529-0131 | ||
| 024 | 7 |
_a10.1002/art.37931 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoulis, Guillaume | |
| 245 | 0 | 0 |
_aMortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cJun 2013 |
||
| 300 |
_a1670-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aSommet, Agnès | |
| 700 | 1 | _aLapeyre-Mestre, Maryse | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 65 _gno. 6 _gp. 1670-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.37931 _zAvailable from publisher's website |
| 999 |
_c22595729 _d22595729 |
||